ARCHITECT 7D71-23Recalls & reported problems
Abbott GmbH · Phosphorus · Class 1
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00380740161736), received between Feb 24, 2022 and Feb 13, 2024 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “High Test Results” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- High Test Results1
- Low Test Results1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryFeb 13, 2024Low Test Results; Low Test Results
THE CUSTOMER OBSERVED FALSELY DECREASED PHOSPHORUS RESULTS GENERATED ON THE ARCHITECT C16000 PROCESSING MODULE FOR MULTIPLE PATIENT SAMPLES. THE CUSTOMER PROVIDED THE FOLLOWING EXAMPLE RESULTS: (CUSTOMER PROVIDED NORMAL RANGE 2.5-4.5 MG/DL) (B)(6) INITIAL RESULT = <0.7 MG/DL, REPEAT RESULT ON (C8000) = 2.1 MG/DL. (B)(6) INITIAL RESULT = 1.3 MG/DL, REPEAT RESULT ON (C8000) = 2.8 MG/DL. (B)(6) INITIAL RESULT = 1.2 MG/DL, REPEAT RESULT ON (C8000) = 2.7 MG/DL. (B)(6) INITIAL RESULT = 0.9 MG/DL, REPEAT RESULT ON (C8000) = 2.3 MG/DL. (B)(6) INITIAL RESULT = 1.7 MG/DL, REPEAT RESULT ON (C8000) = 3.2 MG/DL. (B)(6) INITIAL RESULT = <0.7 MG/DL, REPEAT RESULT ON (C8000) = 1.8 MG/DL. (B)(6) INITIAL RESULT = 1.7 MG/DL, REPEAT RESULT ON (C8000) = 3.3 MG/DL. (B)(6) INITIAL RESULT = 1.2 MG/DL, REPEAT RESULT ON (C8000) = 2.6 MG/DL. (B)(6) INITIAL RESULT = 1.6 MG/DL, REPEAT RESULT ON (C8000) = 3.0 MG/DL. (B)(6) INITIAL RESULT = 0.8 MG/DL, REPEAT RESULT ON (C8000) = 2.1 MG/DL. THE CUSTOMER REPORTED AN UNKNOWN NUMBER OF PATIENTS WERE PROVIDED AN UNSPECIFIED TREATMENT BASED ON RESULTS AND IS NOT AWARE OF ANY ADVERSE EFFECT ON THE PATIENTS. THE RESULTS WERE THEN REPEATED ON THE ARCHITECT C8000 AND THE C
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18694258 ↗MalfunctionFeb 24, 2022High Test Results; High Test Results
THE CUSTOMER STATED THAT DISCREPANT ARCHITECT PHOSPHORUS RESULTS WERE GENERATED FOR PATIENT SAMPLE ID (B)(6). AN INITIAL RESULT OF 0.94 MMOL/L WAS GENERATED (WITHIN NORMAL RANGE) AND THE CUSTOMER DECIDED TO RETEST THE SAMPLE WHICH RETESTED AT <0.21 MMOL/L (BELOW NORMAL RANGE) USING TWO DIFFERENT REAGENT LOTS. THE CUSTOMER USES SAMPLE COLLECTION TUBES WITH A SEPARATING GEL. IT IS SUSPECTED THAT THE SAMPLE PROBE POSSIBLY WENT INTO THE GEL. NO ADVERSE IMPACT TO PATIENT MANAGEMENT WAS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13592656 ↗
Other Phosphomolybdate (colorimetric), inorganic phosphorus devices
- Synchron 467868Beckman Coulter, Inc. · Phosphomolybdate (Colorimetric), Inorganic Phosphorus1 recall0 reports
- VITROS 1513209Ortho-Clinical Diagnostics, Inc. · Phosphomolybdate (colorimetric), inorganic phosphorus1 recall0 reports
- Phosphate (Inorganic) ver.2 03183793122Roche Diagnostics GmbH · Phosphomolybdate (colorimetric), inorganic phosphorus11 reports
- Phosphate (Inorganic) ver.2 5171377190Roche Diagnostics GmbH · Phosphomolybdate (colorimetric), inorganic phosphorus5 reports
- Phosphate (Inorganic) ver.2 08058610190Roche Diagnostics GmbH · Phosphomolybdate (colorimetric), inorganic phosphorus4 reports
- Dimension Vista® Flex® reagent cartridge PHOS 10445144Siemens Healthcare Diagnostics Inc. · Phosphomolybdate (colorimetric), inorganic phosphorus1 report
- Alinity 08P4030Abbott GmbH · Phosphomolybdate (colorimetric), inorganic phosphorus1 report
- Atellica CH IP 11097611Siemens Healthcare Diagnostics Inc. · Phosphomolybdate (colorimetric), inorganic phosphorus1 report
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.